From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy.

Du, Jing-Jing; Su, Zhenhong; Yu, Haoyi; Qin, Sanhai; Wang, Dongyuan.

Afiliação

Du JJ; Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, College of Medicine, Hubei Polytechnic University, Huangshi, China.
Su Z; Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, College of Medicine, Hubei Polytechnic University, Huangshi, China.
Yu H; Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, College of Medicine, Hubei Polytechnic University, Huangshi, China.
Qin S; Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, College of Medicine, Hubei Polytechnic University, Huangshi, China.
Wang D; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Front Chem ; 10: 1107600, 2022.

Article em En | MEDLINE | ID: mdl-36733612